Novel Oxadiazole‐Based Bioisostere of Caffeic Acid Phenethyl Ester: Synthesis, Anticancer Activity, and Inhibition of Lipoxygenase Product Biosynthesis
Drug Development Research · 2025
DOI: 10.1002/ddr.70099 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Development Research, 2025. Verfasst von Mika A Robichaud und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, Université de Moncton, Moncton, New Brunswick, Canada. Hauptthemen laut MEDLINE: Lipoxygenase Inhibitors, Caffeic Acids, Oxadiazoles, Phenylethyl Alcohol. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Caffeic acid phenethyl ester ( 1 ), a honeybee propolis component, possesses many bioactive properties, making it a useful scaffold for drug research. Further, CAPE ( 1 ) is a more effective inhibitor of the biosynthesis of 5‐lipoxygenase (5‐LO) products compared to Zileuton, the only clinically‐approved direct 5‐LO inhibitor. However, CAPE ( 1 ) suffers from a poor metabolic profile, being rapidly metabolized to caffeic acid (CA). In this study, we synthesized and performed several biological assays on a new bioisostere of CAPE ( 1 ) possessing a 1,2,4‐oxadiazole ring. The new bioisostere (OB‐CAPE ( 5 )) has a similar antiproliferative effect to CAPE ( 1 ) on NCI‐60 cancer cell lines and maintains the activity of CAPE ( 1 ) as an inhibitor of the biosynthesis of 5‐, 12‐ and 15‐LO products and as an iron chelator. In human polymorphonuclear leukocytes, OB‐CAPE ( 5 ) inhibits the biosynthesis of 5‐LO products with an IC 50 of 0.93 µM compared to 1.0 µM for CAPE ( 1 ). Both compounds have similar antioxidant activity, with IC 50 values of 1.2 µM for OB‐CAPE ( 5 ) and 1.1 µM for CAPE ( 1 ). The new hydrogen bond predicted for the oxadiazole ring and the GLN363 amino acid in the 5‐LO active site may explain the small improvement in the affinity of OB‐CAPE ( 5 ) for the protein compared to CAPE ( 1 ). Finally, stability studies in human plasma reveal that OB‐CAPE ( 5 ) is 25% more stable than CAPE ( 1 ). Therefore, the increase in stability associated with the replacement of the ester function with its bioisostere, while maintaining the anti‐inflammatory and anticancer properties of CAPE ( 1 ), suggests that OB‐CAPE ( 5 ) may be a comparable yet more stable candidate for in vivo studies in disease models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry, Université de Moncton, Moncton, New Brunswick, Canada.
- New Brunswick Center for Precision Medicine, Moncton, New Brunswick, Canada.
- Atlantic Cancer Research Institute, Moncton, New Brunswick, Canada.
ORCID-Profile: Mohamed Touaibia
Zitieren
APA
Robichaud, M. A., Chiasson, A. I., Doiron, J. A., Hébert, M. P. A., Surette, M. E., & Touaibia, M. (2025). Novel Oxadiazole‐Based Bioisostere of Caffeic Acid Phenethyl Ester: Synthesis, Anticancer Activity, and Inhibition of Lipoxygenase Product Biosynthesis. Drug Development Research. https://doi.org/10.1002/ddr.70099
Vancouver
Robichaud MA, Chiasson AI, Doiron JA, Hébert MPA, Surette ME, Touaibia M. Novel Oxadiazole‐Based Bioisostere of Caffeic Acid Phenethyl Ester: Synthesis, Anticancer Activity, and Inhibition of Lipoxygenase Product Biosynthesis. Drug Development Research. 2025. doi:10.1002/ddr.70099
BibTeX
@article{Robichaud2025,
author = {Robichaud, Mika A and Chiasson, Audrey Isabel and Doiron, Jérémie A and Hébert, Mathieu P A and Surette, Marc E and Touaibia, Mohamed},
title = {Novel Oxadiazole‐Based Bioisostere of Caffeic Acid Phenethyl Ester: Synthesis, Anticancer Activity, and Inhibition of Lipoxygenase Product Biosynthesis},
journal = {Drug Development Research},
year = {2025},
doi = {10.1002/ddr.70099}
}
EUVIMED